Casdin Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26.6M Sell
81,500
-38,500
-32% -$12.6M 2.42% 9
2025
Q1
$32.4M Sell
120,000
-20,000
-14% -$5.4M 2.65% 8
2024
Q4
$32.9M Sell
140,000
-30,000
-18% -$7.06M 2.19% 11
2024
Q3
$46.8M Hold
170,000
3.12% 9
2024
Q2
$41.3M Sell
170,000
-188,000
-53% -$45.7M 3.15% 10
2024
Q1
$53.5M Buy
358,000
+163,000
+84% +$24.4M 3.98% 6
2023
Q4
$37.3M Sell
195,000
-5,000
-3% -$957K 3.66% 9
2023
Q3
$35.4M Sell
200,000
-80,000
-29% -$14.2M 3.92% 9
2023
Q2
$53.2M Buy
280,000
+10,000
+4% +$1.9M 4.65% 5
2023
Q1
$54.1M Sell
270,000
-95,000
-26% -$19M 4.46% 6
2022
Q4
$86.7M Sell
365,000
-283,000
-44% -$67.3M 6.72% 4
2022
Q3
$130M Sell
648,000
-157,000
-20% -$31.4M 8.52% 4
2022
Q2
$117M Sell
805,000
-195,000
-20% -$28.4M 9.93% 2
2022
Q1
$163M Hold
1,000,000
7.32% 2
2021
Q4
$170M Hold
1,000,000
4.78% 5
2021
Q3
$189M Hold
1,000,000
4.7% 6
2021
Q2
$170M Buy
1,000,000
+120,000
+14% +$20.3M 4.3% 7
2021
Q1
$124M Buy
880,000
+100,000
+13% +$14.1M 3.7% 7
2020
Q4
$101M Buy
780,000
+160,000
+26% +$20.8M 3% 11
2020
Q3
$90.3M Buy
620,000
+70,000
+13% +$10.2M 4.04% 7
2020
Q2
$81.5M Sell
550,000
-35,000
-6% -$5.18M 4.82% 6
2020
Q1
$63.7M Buy
585,000
+70,000
+14% +$7.62M 6.76% 3
2019
Q4
$59.3M Sell
515,000
-85,000
-14% -$9.79M 5.45% 6
2019
Q3
$48.3M Sell
600,000
-50,000
-8% -$4.02M 4.99% 9
2019
Q2
$47.2M Buy
650,000
+205,000
+46% +$14.9M 4.41% 10
2019
Q1
$41.6M Buy
445,000
+90,000
+25% +$8.41M 4.57% 10
2018
Q4
$25.9M Buy
355,000
+85,000
+31% +$6.2M 4.43% 11
2018
Q3
$23.6M Hold
270,000
2.87% 17
2018
Q2
$26.6M Buy
270,000
+20,000
+8% +$1.97M 3.72% 12
2018
Q1
$29.8M Buy
250,000
+50,000
+25% +$5.96M 5.24% 7
2017
Q4
$25.4M Hold
200,000
6.19% 6
2017
Q3
$23.5M Buy
200,000
+95,000
+90% +$11.2M 6.64% 3
2017
Q2
$8.38M Buy
105,000
+50,000
+91% +$3.99M 3.1% 11
2017
Q1
$2.82M Sell
55,000
-30,000
-35% -$1.54M 1.66% 24
2016
Q4
$3.18M Buy
85,000
+46,000
+118% +$1.72M 2.63% 16
2016
Q3
$2.64M Sell
39,000
-33,500
-46% -$2.27M 2.14% 16
2016
Q2
$4.02M Sell
72,500
-17,500
-19% -$971K 4% 10
2016
Q1
$5.65M Buy
90,000
+30,000
+50% +$1.88M 6.48% 7
2015
Q4
$5.65M Buy
+60,000
New +$5.65M 4.99% 11